![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ACOX1 |
Gene summary for ACOX1 |
![]() |
Gene information | Species | Human | Gene symbol | ACOX1 | Gene ID | 51 |
Gene name | acyl-CoA oxidase 1 | |
Gene Alias | ACOX | |
Cytomap | 17q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q15067 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51 | ACOX1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.13e-06 | 6.12e-01 | -0.1808 |
51 | ACOX1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.65e-08 | 5.83e-01 | -0.0811 |
51 | ACOX1 | HTA11_78_2000001011 | Human | Colorectum | AD | 3.34e-05 | 5.94e-01 | -0.1088 |
51 | ACOX1 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.13e-30 | 9.53e-01 | -0.1954 |
51 | ACOX1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 6.97e-05 | 6.31e-01 | -0.1207 |
51 | ACOX1 | HTA11_83_2000001011 | Human | Colorectum | SER | 7.99e-05 | 6.83e-01 | -0.1526 |
51 | ACOX1 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.29e-09 | 5.58e-01 | -0.1464 |
51 | ACOX1 | HTA11_866_2000001011 | Human | Colorectum | AD | 2.58e-07 | 5.10e-01 | -0.1001 |
51 | ACOX1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.68e-05 | 5.52e-01 | -0.059 |
51 | ACOX1 | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.14e-04 | 6.24e-01 | -0.2061 |
51 | ACOX1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.20e-05 | 4.15e-01 | 0.3859 |
51 | ACOX1 | A015-C-203 | Human | Colorectum | FAP | 1.63e-08 | -1.28e-01 | -0.1294 |
51 | ACOX1 | A001-C-108 | Human | Colorectum | FAP | 1.21e-02 | -9.49e-02 | -0.0272 |
51 | ACOX1 | A002-C-205 | Human | Colorectum | FAP | 7.26e-06 | -1.64e-01 | -0.1236 |
51 | ACOX1 | A015-C-006 | Human | Colorectum | FAP | 4.87e-04 | -2.15e-01 | -0.0994 |
51 | ACOX1 | A002-C-114 | Human | Colorectum | FAP | 1.51e-03 | -7.93e-02 | -0.1561 |
51 | ACOX1 | A015-C-104 | Human | Colorectum | FAP | 2.14e-06 | -1.73e-01 | -0.1899 |
51 | ACOX1 | A001-C-014 | Human | Colorectum | FAP | 2.99e-02 | -1.49e-01 | 0.0135 |
51 | ACOX1 | A002-C-016 | Human | Colorectum | FAP | 1.18e-07 | -1.16e-01 | 0.0521 |
51 | ACOX1 | A015-C-002 | Human | Colorectum | FAP | 3.41e-03 | -2.27e-01 | -0.0763 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003444011 | Liver | Cirrhotic | lipid oxidation | 53/4634 | 108/18723 | 3.85e-08 | 1.27e-06 | 53 |
GO:007232911 | Liver | Cirrhotic | monocarboxylic acid catabolic process | 56/4634 | 122/18723 | 2.87e-07 | 7.01e-06 | 56 |
GO:000906211 | Liver | Cirrhotic | fatty acid catabolic process | 48/4634 | 100/18723 | 3.87e-07 | 9.13e-06 | 48 |
GO:000663512 | Liver | Cirrhotic | fatty acid beta-oxidation | 38/4634 | 74/18723 | 7.41e-07 | 1.57e-05 | 38 |
GO:00725937 | Liver | Cirrhotic | reactive oxygen species metabolic process | 92/4634 | 239/18723 | 1.57e-06 | 3.03e-05 | 92 |
GO:004424212 | Liver | Cirrhotic | cellular lipid catabolic process | 82/4634 | 214/18723 | 6.91e-06 | 1.08e-04 | 82 |
GO:001604212 | Liver | Cirrhotic | lipid catabolic process | 112/4634 | 320/18723 | 2.31e-05 | 3.03e-04 | 112 |
GO:003025811 | Liver | Cirrhotic | lipid modification | 75/4634 | 212/18723 | 3.33e-04 | 2.87e-03 | 75 |
GO:00066926 | Liver | Cirrhotic | prostanoid metabolic process | 22/4634 | 49/18723 | 1.64e-03 | 1.05e-02 | 22 |
GO:00066936 | Liver | Cirrhotic | prostaglandin metabolic process | 22/4634 | 49/18723 | 1.64e-03 | 1.05e-02 | 22 |
GO:003355911 | Liver | Cirrhotic | unsaturated fatty acid metabolic process | 43/4634 | 116/18723 | 2.09e-03 | 1.29e-02 | 43 |
GO:000609122 | Liver | HCC | generation of precursor metabolites and energy | 340/7958 | 490/18723 | 4.04e-34 | 2.85e-31 | 340 |
GO:000663122 | Liver | HCC | fatty acid metabolic process | 238/7958 | 390/18723 | 8.24e-14 | 4.84e-12 | 238 |
GO:004428221 | Liver | HCC | small molecule catabolic process | 225/7958 | 376/18723 | 6.50e-12 | 2.80e-10 | 225 |
GO:001605421 | Liver | HCC | organic acid catabolic process | 152/7958 | 240/18723 | 5.11e-11 | 1.92e-09 | 152 |
GO:00463952 | Liver | HCC | carboxylic acid catabolic process | 149/7958 | 236/18723 | 1.11e-10 | 3.87e-09 | 149 |
GO:004424222 | Liver | HCC | cellular lipid catabolic process | 134/7958 | 214/18723 | 2.07e-09 | 5.79e-08 | 134 |
GO:001939522 | Liver | HCC | fatty acid oxidation | 72/7958 | 103/18723 | 1.63e-08 | 3.92e-07 | 72 |
GO:000906221 | Liver | HCC | fatty acid catabolic process | 70/7958 | 100/18723 | 2.34e-08 | 5.44e-07 | 70 |
GO:003444021 | Liver | HCC | lipid oxidation | 73/7958 | 108/18723 | 1.17e-07 | 2.25e-06 | 73 |
Page: 1 2 3 4 5 6 7 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa01200 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
hsa00640 | Colorectum | AD | Propanoate metabolism | 18/2092 | 32/8465 | 1.33e-04 | 1.11e-03 | 7.08e-04 | 18 |
hsa00071 | Colorectum | AD | Fatty acid degradation | 20/2092 | 43/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 20 |
hsa012001 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
hsa006401 | Colorectum | AD | Propanoate metabolism | 18/2092 | 32/8465 | 1.33e-04 | 1.11e-03 | 7.08e-04 | 18 |
hsa000711 | Colorectum | AD | Fatty acid degradation | 20/2092 | 43/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 20 |
hsa000712 | Colorectum | SER | Fatty acid degradation | 15/1580 | 43/8465 | 8.60e-03 | 4.26e-02 | 3.09e-02 | 15 |
hsa000713 | Colorectum | SER | Fatty acid degradation | 15/1580 | 43/8465 | 8.60e-03 | 4.26e-02 | 3.09e-02 | 15 |
hsa012004 | Colorectum | MSS | Carbon metabolism | 43/1875 | 115/8465 | 1.37e-04 | 1.17e-03 | 7.19e-04 | 43 |
hsa000714 | Colorectum | MSS | Fatty acid degradation | 17/1875 | 43/8465 | 7.50e-03 | 2.86e-02 | 1.75e-02 | 17 |
hsa012005 | Colorectum | MSS | Carbon metabolism | 43/1875 | 115/8465 | 1.37e-04 | 1.17e-03 | 7.19e-04 | 43 |
hsa000715 | Colorectum | MSS | Fatty acid degradation | 17/1875 | 43/8465 | 7.50e-03 | 2.86e-02 | 1.75e-02 | 17 |
hsa012006 | Colorectum | FAP | Carbon metabolism | 38/1404 | 115/8465 | 1.04e-05 | 1.44e-04 | 8.76e-05 | 38 |
hsa006406 | Colorectum | FAP | Propanoate metabolism | 15/1404 | 32/8465 | 6.21e-05 | 6.10e-04 | 3.71e-04 | 15 |
hsa000716 | Colorectum | FAP | Fatty acid degradation | 15/1404 | 43/8465 | 2.73e-03 | 1.23e-02 | 7.50e-03 | 15 |
hsa04024 | Colorectum | FAP | cAMP signaling pathway | 51/1404 | 225/8465 | 1.02e-02 | 3.68e-02 | 2.24e-02 | 51 |
hsa012007 | Colorectum | FAP | Carbon metabolism | 38/1404 | 115/8465 | 1.04e-05 | 1.44e-04 | 8.76e-05 | 38 |
hsa006407 | Colorectum | FAP | Propanoate metabolism | 15/1404 | 32/8465 | 6.21e-05 | 6.10e-04 | 3.71e-04 | 15 |
hsa000717 | Colorectum | FAP | Fatty acid degradation | 15/1404 | 43/8465 | 2.73e-03 | 1.23e-02 | 7.50e-03 | 15 |
hsa040241 | Colorectum | FAP | cAMP signaling pathway | 51/1404 | 225/8465 | 1.02e-02 | 3.68e-02 | 2.24e-02 | 51 |
Page: 1 2 3 4 5 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACOX1 | SNV | Missense_Mutation | novel | c.88N>C | p.Thr30Pro | p.T30P | Q15067 | protein_coding | deleterious(0.01) | benign(0.168) | TCGA-AR-A1AQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
ACOX1 | SNV | Missense_Mutation | c.1693N>C | p.Tyr565His | p.Y565H | Q15067 | protein_coding | tolerated(1) | benign(0.001) | TCGA-BH-A0BZ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | CR | |
ACOX1 | SNV | Missense_Mutation | c.781N>G | p.Pro261Ala | p.P261A | Q15067 | protein_coding | tolerated(0.11) | benign(0) | TCGA-BH-A18V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ACOX1 | SNV | Missense_Mutation | rs752885559 | c.731A>G | p.Asn244Ser | p.N244S | Q15067 | protein_coding | tolerated(0.05) | benign(0.048) | TCGA-D8-A1XK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide | SD |
ACOX1 | SNV | Missense_Mutation | rs749413865 | c.414N>C | p.Gln138His | p.Q138H | Q15067 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-E2-A14N-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD |
ACOX1 | insertion | In_Frame_Ins | novel | c.1115_1116insTAGGCAACAAGAATG | p.Ala372_Leu373insArgGlnGlnGluCys | p.A372_L373insRQQEC | Q15067 | protein_coding | TCGA-A2-A0CT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cytoxan | SD | ||
ACOX1 | insertion | In_Frame_Ins | novel | c.1160_1161insAGAAAAAGCAAGGAG | p.Thr387_Gly388insGluLysAlaArgSer | p.T387_G388insEKARS | Q15067 | protein_coding | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | ||
ACOX1 | insertion | Frame_Shift_Ins | novel | c.1158_1159insCTTCAAAAAGAAGTGATTC | p.Thr387LeufsTer10 | p.T387Lfs*10 | Q15067 | protein_coding | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | ||
ACOX1 | insertion | In_Frame_Ins | novel | c.1126_1127insTTCAAGACCAGCTTGATCAACATGGTGAAACCGTGTCTCTAC | p.Gly376delinsValGlnAspGlnLeuAspGlnHisGlyGluThrValSerLeuArg | p.G376delinsVQDQLDQHGETVSLR | Q15067 | protein_coding | TCGA-AN-A03X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ACOX1 | insertion | Frame_Shift_Ins | novel | c.1536_1537insAT | p.Glu513MetfsTer3 | p.E513Mfs*3 | Q15067 | protein_coding | TCGA-AR-A0TY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |